Arseus to buy Brazilian Pharma Nostra for EUR 51m.
Arseus will pay about 60% of the takeover sum upon closing, consisting of EUR 28 million in cash and EUR 4 million in own shares. The remaining EUR 19 million will be paid over a period of three to five years.
Pharma Nostra generated last year a revenue of about EUR 45 million.
Following the acquisition, Arseus expects that the group's revenues will increase this year by between 14% and 18% in annual terms, up from the previously projected range of 8% to 12%. The organic revenue growth is estimated at 3-6% in 2011.
(EUR 1.0 = USD 1.418)
|Printer friendly Cite/link Email Feedback|
|Publication:||ADP News Belgium|
|Date:||Jul 11, 2011|
|Previous Article:||Belgian Van de Velde sales rise 9% Y/Y in H1 2011.|
|Next Article:||Baronie to buy Barry Callebaut's European consumer arm.|